BUPRENORPHINE TRANSDERMAL SYSTEM
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for BUPRENORPHINE TRANSDERMAL SYSTEM, covering 2006-05-03 to 2024-10-31. Get the full timeline:
Most recent: FDA Approved: BUPRENORPHINE TRANSDERMAL SYSTEM — Supplemental Application (Alvogen Inc.)